EE03827B1 - Meetod transkriptaasi pöördinhibiitori kristallimiseks antilahusti kasutamisega - Google Patents
Meetod transkriptaasi pöördinhibiitori kristallimiseks antilahusti kasutamisegaInfo
- Publication number
- EE03827B1 EE03827B1 EEP199900341A EEP9900341A EE03827B1 EE 03827 B1 EE03827 B1 EE 03827B1 EE P199900341 A EEP199900341 A EE P199900341A EE P9900341 A EEP9900341 A EE P9900341A EE 03827 B1 EE03827 B1 EE 03827B1
- Authority
- EE
- Estonia
- Prior art keywords
- solvent
- crystallizing
- transcriptase
- inhibitor
- rotary
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3738597P | 1997-02-05 | 1997-02-05 | |
GBGB9706046.1A GB9706046D0 (en) | 1997-03-24 | 1997-03-24 | Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent |
US4280797P | 1997-04-08 | 1997-04-08 | |
GBGB9709348.8A GB9709348D0 (en) | 1997-05-07 | 1997-05-07 | Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent |
PCT/US1998/001999 WO1998033782A1 (fr) | 1997-02-05 | 1998-02-02 | Procede de cristallisation d'un inhibiteur de transcriptase inverse utilisant un antisolvant |
Publications (2)
Publication Number | Publication Date |
---|---|
EE9900341A EE9900341A (et) | 2000-02-15 |
EE03827B1 true EE03827B1 (et) | 2002-08-15 |
Family
ID=27451618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP199900341A EE03827B1 (et) | 1997-02-05 | 1998-02-02 | Meetod transkriptaasi pöördinhibiitori kristallimiseks antilahusti kasutamisega |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0975609B1 (fr) |
JP (6) | JP3418626B2 (fr) |
KR (1) | KR100573192B1 (fr) |
CN (2) | CN1191242C (fr) |
AT (1) | ATE486065T1 (fr) |
AU (1) | AU738545C (fr) |
CA (1) | CA2279198C (fr) |
CZ (2) | CZ304186B6 (fr) |
DE (1) | DE69841972D1 (fr) |
EA (1) | EA001805B1 (fr) |
EE (1) | EE03827B1 (fr) |
HU (1) | HU229087B1 (fr) |
IL (1) | IL130715A (fr) |
NO (1) | NO320128B1 (fr) |
NZ (1) | NZ336510A (fr) |
PL (1) | PL197740B1 (fr) |
SK (1) | SK284935B6 (fr) |
WO (1) | WO1998033782A1 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE486065T1 (de) * | 1997-02-05 | 2010-11-15 | Merck Sharp & Dohme | Verfahren zur kristallisation eines reverstranskriptase-inhibitors, bei welchem ein anti-lösungsmittel benutzt wird |
AR011731A1 (es) * | 1997-05-16 | 2000-08-30 | Merck & Co Inc | Un proceso de reaccion de adicion enantioselectiva eficiente utilizando un reactivo de organozinc. |
US20010014352A1 (en) | 1998-05-27 | 2001-08-16 | Udit Batra | Compressed tablet formulation |
HRP990182A2 (en) * | 1998-06-11 | 2000-02-29 | Du Pont Pharm Co | Crystalline efavirenz |
GB9828721D0 (en) * | 1998-12-24 | 1999-02-17 | Glaxo Group Ltd | Novel apparatus and process |
US20060235008A1 (en) | 2004-08-19 | 2006-10-19 | Hetero Drugs Limited | Novel polymorphs of efavirenz |
WO2008108630A1 (fr) * | 2007-03-02 | 2008-09-12 | Ultimorphix Technologies B.V. | Formes polymorphes de l'efavirenz |
WO2009087679A2 (fr) * | 2007-12-24 | 2009-07-16 | Matrix Laboratories Limited | Procédé de préparation de formes polymorphes de (s)-6-chloro-(cyclopropyléthynyl)-1,4-dihydro-4-(trifluorométhyl)-2h-3,1-benzoxazin-2-one |
EP2367804B1 (fr) | 2008-12-22 | 2013-11-06 | Hetero Research Foundation | Procédé pour la préparation d'un polymorphe de l'éfavirenz |
DE102009041443A1 (de) | 2009-09-16 | 2011-03-31 | Archimica Gmbh | Salze des 6-Chlor-4-(cyclopropylethinyl)-1,4-dihydro-4-(trifluormethyl)-2H-3,1-benzoxazin-2-ons und deren Synthese, Aufreinigung und Anwendung als Vorstufen für Efavirenz |
EP2471783A1 (fr) | 2010-12-23 | 2012-07-04 | Esteve Química, S.A. | Nouvelle forme polymorphe de l'éfavirenz |
CN103508973B (zh) * | 2012-06-25 | 2016-04-27 | 上海迪赛诺药业有限公司 | 制备依非韦伦i型结晶的方法 |
CN105037175B (zh) * | 2014-07-18 | 2017-02-22 | 盐城迪赛诺制药有限公司 | 一种用于提高依非韦伦中间体光学纯度的方法 |
US10550126B2 (en) | 2015-10-16 | 2020-02-04 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11365198B2 (en) | 2015-10-16 | 2022-06-21 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11512092B2 (en) | 2015-10-16 | 2022-11-29 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11524964B2 (en) | 2015-10-16 | 2022-12-13 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11773106B2 (en) | 2015-10-16 | 2023-10-03 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
CN116270645A (zh) | 2015-10-16 | 2023-06-23 | 艾伯维公司 | 制备咪唑并[1,2-a]吡咯并[2,3-e]吡嗪类化合物及其固态形式的方法 |
CN114195761B (zh) * | 2021-12-23 | 2023-04-14 | 浙江普洛家园药业有限公司 | 一种高纯度西他沙星3/2水合物的制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1282405C (fr) * | 1984-05-21 | 1991-04-02 | Michael R. Violante | Methode pour produire des particules dimensionnellement uniformes a partir des composes organiques insolubles dans l'eau |
IL106507A (en) * | 1992-08-07 | 1997-11-20 | Merck & Co Inc | Pharmaceutical compositions containing benzoxazinones and some novel compounds of this type |
US5663169A (en) * | 1992-08-07 | 1997-09-02 | Merck & Co., Inc. | Benzoxazinones as inhibitors of HIV reverse transcriptase |
AU1694295A (en) * | 1994-01-28 | 1995-08-15 | Merck & Co., Inc. | Benzoxazinones as inhibitors of hiv reverse transcriptase |
US5663467A (en) * | 1995-01-23 | 1997-09-02 | Merck & Co., Inc. | Synthesis of cyclopropylacetylene |
US5633405A (en) * | 1995-05-25 | 1997-05-27 | Merck & Co., Inc. | Asymmetric synthesis of (-)-6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxanzin-2-one |
ATE486065T1 (de) * | 1997-02-05 | 2010-11-15 | Merck Sharp & Dohme | Verfahren zur kristallisation eines reverstranskriptase-inhibitors, bei welchem ein anti-lösungsmittel benutzt wird |
WO1998045278A1 (fr) * | 1997-04-07 | 1998-10-15 | Du Pont Pharmaceuticals Company | Synthese asymetrique de benzoxazinones via de nouveaux intermediaires |
-
1998
- 1998-02-02 AT AT98904853T patent/ATE486065T1/de active
- 1998-02-02 CZ CZ20040883A patent/CZ304186B6/cs not_active IP Right Cessation
- 1998-02-02 WO PCT/US1998/001999 patent/WO1998033782A1/fr active IP Right Grant
- 1998-02-02 KR KR1019997006985A patent/KR100573192B1/ko not_active IP Right Cessation
- 1998-02-02 JP JP53319098A patent/JP3418626B2/ja not_active Expired - Lifetime
- 1998-02-02 CN CNB011227095A patent/CN1191242C/zh not_active Expired - Lifetime
- 1998-02-02 CN CN98802171A patent/CN1073991C/zh not_active Expired - Lifetime
- 1998-02-02 IL IL13071598A patent/IL130715A/xx not_active IP Right Cessation
- 1998-02-02 CZ CZ0276599A patent/CZ297535B6/cs not_active IP Right Cessation
- 1998-02-02 SK SK1055-99A patent/SK284935B6/sk not_active IP Right Cessation
- 1998-02-02 EA EA199900720A patent/EA001805B1/ru not_active IP Right Cessation
- 1998-02-02 CA CA002279198A patent/CA2279198C/fr not_active Expired - Lifetime
- 1998-02-02 EP EP98904853A patent/EP0975609B1/fr not_active Expired - Lifetime
- 1998-02-02 EE EEP199900341A patent/EE03827B1/xx unknown
- 1998-02-02 AU AU62632/98A patent/AU738545C/en not_active Expired
- 1998-02-02 NZ NZ336510A patent/NZ336510A/en not_active IP Right Cessation
- 1998-02-02 DE DE69841972T patent/DE69841972D1/de not_active Expired - Lifetime
- 1998-02-02 PL PL334478A patent/PL197740B1/pl unknown
- 1998-02-02 HU HU0001313A patent/HU229087B1/hu unknown
-
1999
- 1999-08-04 NO NO19993779A patent/NO320128B1/no not_active IP Right Cessation
-
2002
- 2002-06-04 JP JP2002163198A patent/JP2003040874A/ja not_active Withdrawn
-
2010
- 2010-09-10 JP JP2010202879A patent/JP5295190B2/ja not_active Expired - Lifetime
-
2013
- 2013-04-22 JP JP2013089216A patent/JP2013139484A/ja active Pending
-
2015
- 2015-07-24 JP JP2015146631A patent/JP6126172B2/ja not_active Expired - Lifetime
-
2017
- 2017-01-11 JP JP2017002745A patent/JP2017061575A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE03827B1 (et) | Meetod transkriptaasi pöördinhibiitori kristallimiseks antilahusti kasutamisega | |
HUP9800266A2 (hu) | Eljárás szerves vegyületek kinyerésére oldataikból | |
CY1111841T1 (el) | Πολυμορφικη μορφη του 2-(3-κυανο-4-ισοβουτυλοξυφαινυλ)-4-μεθυλ-5-θειαζολοκαρβοξυλικου οξεος και μεθοδος παρασκευης της ιδιας | |
NO20021447L (no) | Fremgangsmåte for syntese av silisiumaluminiumfosfatmolekylsiler | |
KR910020031A (ko) | 펩티드 아미드, 이의 제조방법 및 피브린/트롬빈 응괴 억제제로서 이를 함유하는 약제 | |
BR0114170A (pt) | Método e equipamento para o processamento de bits indicadores de paging transmitidos em um canal de paging rápido | |
TWI263872B (en) | Cleaning solution used in photolithography and a method of treating substrate | |
DK1429664T3 (da) | Fremgangsmåde til dannelse af modhager på en suturtråd og apparat til udförelse af denne | |
RU98104585A (ru) | Радиотелефон и способ функционирования радиотелефона в прерывистом режиме поисковых вызовов | |
DE69529813D1 (de) | Selbstreflektierender film mit verbesserter deckschicht | |
DE59608749D1 (de) | Verfahren zur herstellung transdermaler therapeutischer pflaster (tts) | |
BR9800515A (pt) | Processo para a preparação de um sistema catalisador de metaloceno | |
EA199900552A1 (ru) | Асимметрический способ получения бензоксазинонов | |
DE69112379D1 (de) | Neues kristallisationsverfahren von steroidverbindungen und so produzierte verbindungen. | |
DK0980248T3 (da) | Forbedringer af eller vedrørende langtidsvirkende antibiotika | |
DK0955308T3 (da) | Fremgangsmåde til omsaltning og oprensning af oligopeptider i ét trin | |
BR0011815A (pt) | Processo para a purificação de poloxâmeros que contêm impurezas de aldeìdo, e, poloxâmero | |
NO823002L (no) | Fremgangsmaate for rensing eller isolering av dipeptidforbindelser | |
DE59909870D1 (de) | Verfahren zur epoxidierung von olefinen | |
Tanaka et al. | Infrared absorption spectra of organic sulfur compounds. I. Studies on SN stretching bands of benzenesulfonamide derivatives | |
ATE271551T1 (de) | Verfahren zur herstellung von n-(1-(s)- ethoxycarbonyl-3-phenylpropyl)-l-alanin-n- carboxyanhydrid | |
BR0010049A (pt) | Processo para purificação de esteróis a partir de extratos de hidrocarboneto usando fracionamento por evaporação | |
Godfrey Jr et al. | Synthesis of peptide-derived amino alcohols. 1. Potential transition-state inhibitors of angiotensin-converting enzyme | |
FI874330A0 (fi) | Foerfarande foer oevervakning av framstaellningen av en lineaer kombination av aminosyrarester. | |
JPH10200941A (ja) | 基地局決定装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB4A | Valid patent at the end of a year |
Effective date: 20021231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20031231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20041231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20091231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20101231 |
|
HC1A | Change of owner name |